Leg lengthening and deformity correction in rare bone diseases: a multidisciplinary approach

Mindler, Gabriel T.; Stauffer, Alexandra; Rudolf, G.

doi:10.1007/s10354-020-00805-7

Cited by 8 publications

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Many of these conditions have subtle features that must be considered in the application of limb reconstruction techniques. Mindler et al reviewed considerations regarding deformity correction and prevention, skeletal protection, and lengthening in a number of specific conditions, including achondroplasia, X-linked hypophosphatemia, and osteogenesis imperfecta 23 . They suggested a highly multidisciplinary approach to both the treatment and decision-making regarding these patients.…”

Section: Bone Dysplasias and Tumorsmentioning

confidence: 99%

What’s New in Limb Lengthening and Deformity Correction

Georgiadis

Morrison

Dahl

2021

Journal of Bone and Joint Surgery

View full text Add to dashboard Cite

The purpose of this form is to provide readers of your manuscript with information about your other interests that could influence how they receive and understand your work. The form is designed to be completed electronically and stored electronically. It contains programming that allows appropriate data display. Each author should submit a separate form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts. Identifying information. The work under consideration for publication.This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the work itself, from the initial conception and planning to the present. The requested information is about resources that you received, either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work without receiving any financial support from any third party --that is, the work was supported by funds from the same institution that pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check "Yes". Relevant financial activities outside the submitted work.This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor (EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer in general, not just in the area of EGFR or lung cancer.Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved and drugs w...

show abstract

Section: Bone Dysplasias and Tumorsmentioning

confidence: 99%